Functional Adult Outcomes 16 Years After Childhood Diagnosis of Attention-Deficit/Hyperactivity Disorder: MTA Results
- PMID: 27806862
- PMCID: PMC5113724
- DOI: 10.1016/j.jaac.2016.07.774
Functional Adult Outcomes 16 Years After Childhood Diagnosis of Attention-Deficit/Hyperactivity Disorder: MTA Results
Erratum in
-
Corrigendum.J Am Acad Child Adolesc Psychiatry. 2017 Jul;56(7):628. doi: 10.1016/j.jaac.2017.05.006. Epub 2017 Jun 21. J Am Acad Child Adolesc Psychiatry. 2017. PMID: 28647017 No abstract available.
-
Corrigendum.J Am Acad Child Adolesc Psychiatry. 2018 Mar;57(3):225. doi: 10.1016/j.jaac.2018.01.007. J Am Acad Child Adolesc Psychiatry. 2018. PMID: 29496133 No abstract available.
Abstract
Objective: To compare educational, occupational, legal, emotional, substance use disorder, and sexual behavior outcomes in young adults with persistent and desistent attention-deficit/hyperactivity disorder (ADHD) symptoms and a local normative comparison group (LNCG) in the Multimodal Treatment Study of Children with ADHD (MTA).
Method: Data were collected 12, 14, and 16 years postbaseline (mean age 24.7 years at 16 years postbaseline) from 476 participants with ADHD diagnosed at age 7 to 9 years, and 241 age- and sex-matched classmates. Probands were subgrouped on persistence versus desistence of DSM-5 symptom count. Orthogonal comparisons contrasted ADHD versus LNCG and symptom-persistent (50%) versus symptom-desistent (50%) subgroups. Functional outcomes were measured with standardized and demographic instruments.
Results: Three patterns of functional outcomes emerged. Post-secondary education, times fired/quit a job, current income, receiving public assistance, and risky sexual behavior showed the most common pattern: the LNCG group fared best, symptom-persistent ADHD group worst, and symptom-desistent ADHD group between, with the largest effect sizes between LNCG and symptom-persistent ADHD. In the second pattern, seen with emotional outcomes (emotional lability, neuroticism, anxiety disorder, mood disorder) and substance use outcomes, the LNCG and symptom-desistent ADHD group did not differ, but both fared better than the symptom-persistent ADHD group. In the third pattern, noted with jail time (rare), alcohol use disorder (common), and number of jobs held, group differences were not significant. The ADHD group had 10 deaths compared to one death in the LNCG.
Conclusion: Adult functioning after childhood ADHD varies by domain and is generally worse when ADHD symptoms persist. It is important to identify factors and interventions that promote better functional outcomes.
Keywords: ADHD; MTA; adult outcomes; follow-up; functional outcomes.
Copyright © 2016 American Academy of Child and Adolescent Psychiatry. Published by Elsevier Inc. All rights reserved.
Figures
Comment in
-
New Insights From the MTA: Who Outgrows Attention-Deficit/Hyperactivity Disorder and What Becomes of Those Who Don't?J Am Acad Child Adolesc Psychiatry. 2016 Nov;55(11):925-926. doi: 10.1016/j.jaac.2016.07.775. J Am Acad Child Adolesc Psychiatry. 2016. PMID: 27806857 No abstract available.
References
-
- Cherkasova M, Mongia M, Errington T, Ponde M, Hechtman L. Clinical Management of Attention Deficit Hyperactivity Disorder. London: Future Medicine Ltd; 2013. Long-term outcome in ADHD and its predictors; pp. 148–160.
-
- Weiss G, Hechtman LT. Hyperactive Children Grown up: ADHD in Children, Adolescents, and Adults. 2. New York: Guilford Press; 1993.
-
- Barkley RA, Murphy KR, Fischer M. ADHD in Adults: What the Science Says. New York: Guilford Press; 2008.
Publication types
MeSH terms
Grants and funding
- HHSN271200800003C/DA/NIDA NIH HHS/United States
- HHSN271200800005C/DA/NIDA NIH HHS/United States
- U01 MH050467/MH/NIMH NIH HHS/United States
- HHSN271200800006C/DA/NIDA NIH HHS/United States
- N01 MH012008/MH/NIMH NIH HHS/United States
- U01 MH050461/MH/NIMH NIH HHS/United States
- N01 MH012007/MH/NIMH NIH HHS/United States
- HHSN271200800008C/DA/NIDA NIH HHS/United States
- HHSN271200800004C/DA/NIDA NIH HHS/United States
- U01 MH050440/MH/NIMH NIH HHS/United States
- N01 DA085548/DA/NIDA NIH HHS/United States
- N01 MH012012/MH/NIMH NIH HHS/United States
- N01 MH012010/MH/NIMH NIH HHS/United States
- HHSN271200800009C/DA/NIDA NIH HHS/United States
- N01 MH012011/MH/NIMH NIH HHS/United States
- K23 DA032577/DA/NIDA NIH HHS/United States
- N01 MH012004/MH/NIMH NIH HHS/United States
- N01 MH012009/MH/NIMH NIH HHS/United States
- U01 MH050453/MH/NIMH NIH HHS/United States
- HHSN271200800007C/DA/NIDA NIH HHS/United States
- R01 DA039881/DA/NIDA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
